Literature DB >> 18545928

Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy.

Susanna Usai1, Licia Grazzi, Domenico D'Amico, Frank Andrasik, Gennaro Bussone.   

Abstract

The 6-item Headache Impact Test questionnaire (HIT-6) is a simple and reliable tool to measure the impact headaches have on patients' lives. Patients with chronic migraine (CM) and medication overuse are markedly impaired in their functional activity. The aim of this study was to investigate the responsiveness of the HIT-6 tool to clinical changes induced by treatment in patients with CM and medication overuse. A sample of 160 patients underwent a day-hospital withdrawal treatment followed by prophylaxis. Sixty-two of them completed the 12-month follow up. Patients improved significantly after treatment intervention, as days of headache per month and medications/month decreased from baseline to follow up. Also HIT-6 scores improved, with mean score decreasing from 65+/-5.4 (median 65) to 59.4+/-8.5 (median 62) (Student's t-test p<0.00001) and with a reduction in the percentage of patients with very severe headache-related impact one year after withdrawal therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18545928     DOI: 10.1007/s10072-008-0918-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  14 in total

1.  Quality-of-life differences between patients with episodic and transformed migraine.

Authors:  D M Meletiche; J H Lofland; W B Young
Journal:  Headache       Date:  2001-06       Impact factor: 5.887

Review 2.  Chronic daily headache.

Authors:  S D Silberstein; R B Lipton
Journal:  Curr Opin Neurol       Date:  2000-06       Impact factor: 5.710

3.  Psychometric properties of the HIT-6 among patients in a headache-specialty practice.

Authors:  Ariane K Kawata; Remy R Coeytaux; Robert F Devellis; Alan G Finkel; J Douglas Mann; Kevin Kahn
Journal:  Headache       Date:  2005-06       Impact factor: 5.887

4.  Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).

Authors:  E Vuillaume De Diego; M Lanteri-Minet
Journal:  Cephalalgia       Date:  2005-03       Impact factor: 6.292

5.  The impact of migraine on quality of life in the general population: the GEM study.

Authors:  G M Terwindt; M D Ferrari; M Tijhuis; S M Groenen; H S Picavet; L J Launer
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

6.  Chronic daily headache in a primary care population: prevalence and headache impact test scores.

Authors:  Remy R Coeytaux; Julie C Linville
Journal:  Headache       Date:  2007-01       Impact factor: 5.887

7.  A comparison of disability and psychological factors in migraine and transformed migraine.

Authors:  J E Magnusson; W J Becker
Journal:  Cephalalgia       Date:  2002-04       Impact factor: 6.292

8.  A six-item short-form survey for measuring headache impact: the HIT-6.

Authors:  M Kosinski; M S Bayliss; J B Bjorner; J E Ware; W H Garber; A Batenhorst; R Cady; C G H Dahlöf; A Dowson; S Tepper
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

9.  Quality of life in migraine and chronic daily headache patients.

Authors:  M J Monzón; M J Láinez
Journal:  Cephalalgia       Date:  1998-11       Impact factor: 6.292

10.  Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.

Authors:  Marcelo E Bigal; Alan M Rapoport; Richard B Lipton; Stewart J Tepper; Fred D Sheftell
Journal:  Headache       Date:  2003-04       Impact factor: 5.887

View more
  5 in total

Review 1.  Medication overuse headache: a critical review of end points in recent follow-up studies.

Authors:  Knut Hagen; Rigmor Jensen; Magne Geir Bøe; Lars Jacob Stovner
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

Review 2.  Disability in chronic daily headache: state of the art and future directions.

Authors:  Domenico D'Amico; L Grazzi; S Usai; A Raggi; M Leonardi; G Bussone
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

3.  [Classification and therapy of medication-overuse headache: impact of the third edition of the International Classification of Headache Disorders].

Authors:  H Göbel; K Heinze-Kuhn; I Petersen; C Göbel; A Göbel; A Heinze
Journal:  Schmerz       Date:  2014-04       Impact factor: 1.107

4.  Measuring interictal burden among people affected by migraine: a descriptive survey study.

Authors:  Lena T Hubig; Timothy Smith; Emma Williams; Lauren Powell; Karissa Johnston; Linda Harris; Gilbert L'Italien; Vladimir Coric; Andrew J Lloyd; Siu Hing Lo
Journal:  J Headache Pain       Date:  2022-08-08       Impact factor: 8.588

5.  Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine.

Authors:  Regina Rendas-Baum; Min Yang; Sepideh F Varon; Lisa M Bloudek; Ronald E DeGryse; Mark Kosinski
Journal:  Health Qual Life Outcomes       Date:  2014-08-01       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.